"The addition of IMS to our Medivators Endoscopy segment compliments this business with the most competitive global AER portfolio and adds key global R&D and manufacturing capabilities to our organization," said Jorgen Hansen, President of Medivators and COO of Cantel Medical. "We look forward to manufacturing both IMS' line of chemistries as well as Medivators' range of infection prevention chemistries at the IMS facility for sale throughout the European continent."

We use cookies on this website to ensure that the site will work properly. If you click ‘OK’ or continue to use this website by navigating to another page you are agreeing to our use of cookies.

More information